fda semaglutide compounding warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of July 29, 2024: FDA issued

Go to the ER if you experience decreased urination, swelling in the ankles or legs, fatigue, or shortness of breath

Regarding their protective effect against stroke, GLP-1RAs showed some heterogeneity in CVOTs, with the highest reduction in the risk of ischemic stroke reported for the long-acting GLP1-RA semaglutide at 28% [16] and no reduction for the short-acting lixisenatide [1]

The risk of infection is extremely low

From my consultation to finding a plan that worked for me, all of the girls I've spoken to have been so informative and helpful

Angiogenesis could be a potent therapy for stroke patients by increasing the cerebral blood flow

The process is straightforward, communication is consistent, and everything feels organized and professional